Everyone take a breath The SP falls 30 cents on mediocre volume and the negativity comes out. If the SP had gone up 30 cents on mediocre volume - everything is great.
The CC was quite positive, and we finally got to here Henri speak. And then the whiners complain about the way he speaks . . .
Everyone who asked a question complimented management on a strong quarter.
Unfortunately, bio-pharmas take many years to develop. So let's all stop watching this unfold on an hourly basis.
As for more fun with numbers, the SP doesn't reflect any value for Nestle/Yoplait anyways. If it was trading at $7 - all the whiners/worryers would have a point. But its not, so they don't.
NTB's market cap is only $123M. Acasti's is $89M. Back out the cash, and the SP attributable to NTB's NKO and Onemia business is a measly $50M or about a $1/share - or the same value from the 3 years ago financial crisis.
This market is not assigning any value for future growth - thats just the way it is. Not really management's fault. So take your money and go buy some bank stock. Because NTB is going to be a slow grind until the Acasti trials bear fruit, and until sales and product of NKO reach meaningful levels.
This SP range is probably a bottom, so should only move north from here - but at a slow pace. Still beats a GIC paying 1%.